Nordea Investment Management
BPMC

Nordea Investment Management’s Blueprint Medicines BPMC Stock Holding History

Nordea Investment Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-31,810
Closed -$1.59M – 966
2022
Q2 		$1.59M Sell
31,810
-3,027
-9% -$177K ﹤0.01% 723
2022
Q1 		$2.28M Hold
34,837
– – ﹤0.01% 685
2021
Q4 		$3.87M Sell
34,837
-483
-1% -$50.5K ﹤0.01% 625
2021
Q3 		$3.69M Buy
+35,320
New +$3.29M ﹤0.01% 648

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Nordea Investment Management's BPMC Position: Q3 2022 in Review

Nordea Investment Management sold out of Blueprint Medicines (BPMC) in Q3 2022, closing a stake of 31,810 shares — an estimated $1.59M sold.

Nordea Investment Management first reported a position in BPMC in Q3 2021 and held it in 4 quarters. The position peaked at $3.87M in Q4 2021. 240 funds tracked by Wall St. Rank hold BPMC as of Q3 2022.

  • Nordea Investment Management reported no remaining Blueprint Medicines position as of Q3 2022 after selling out during the quarter.
  • Nordea Investment Management sold 31,810 Blueprint Medicines shares in Q3 2022, an estimated $1.59M.
  • Nordea Investment Management first reported a position in Blueprint Medicines in Q3 2021 and held it in 4 quarters.
  • Nordea Investment Management's Blueprint Medicines position peaked at $3.87M in Q4 2021.
  • 240 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2022.

Based on Nordea Investment Management's 13F filing for Q3 2022, filed 19 Oct 2022.